本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Can-Fite Biopharma Ltd

3.14
-0.1500-4.56%
盤後3.12-0.0200-0.64%19:21 EDT
成交量:3.41萬
成交額:10.95萬
市值:672.76萬
市盈率:0.00
高:3.29
開:3.27
低:3.11
收:3.29
52周最高:36.40
52周最低:3.11
股本:214.25萬
流通股本:210.50萬
量比:0.91
換手率:1.62%
股息:- -
股息率:- -
每股收益(TTM):-2,665.2840
每股收益(LYR):-3,259.3317
淨資產收益率:-264.12%
總資產收益率:-81.86%
市淨率:1.61
市盈率(LYR):0.00

資料載入中...

2020/01/09

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/08

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/03

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/20

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/09

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/29

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/19

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/24

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/10/18

[修訂]招股説明書

[Amend] Registration statement for certain foreign private issuers
2019/10/18

SEC問詢函

[Cover]Correspondence
2019/10/17

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/10/17

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]